05/14/2024
11:32 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:06 PM | ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:06 PM | ADC Therapeutics (Subject)
MALLIK AMEET (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024
5:51 AM | ADC Therapeutics (Filer)
| Form 424B5 | |
05/06/2024
5:38 AM | ADC Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
5:29 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2024
8:31 PM | ADC Therapeutics (Subject)
Oaktree Capital Group Holdings GP, LLC (Filed by)
| Form SC 13G | |
|
04/26/2024
3:21 PM | ADC Therapeutics (Filer)
| Form DEFA14A | |
04/16/2024
3:16 PM | ADC Therapeutics (Filer)
| Form PRE 14A | |
04/09/2024
3:06 PM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:11 PM | ADC Therapeutics (Filer)
| Form 424B3 | |
03/15/2024
3:11 PM | ADC Therapeutics (Filer)
| Form 424B3 | |
03/14/2024
11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/14/2024
11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/14/2024
11:15 PM | ADC Therapeutics (Filer)
| Form EFFECT | |
03/13/2024
3:17 PM | ADC Therapeutics (Filer)
| Form POS AM | |
03/13/2024
3:14 PM | ADC Therapeutics (Filer)
| Form POS AM | |
03/13/2024
2:19 PM | ADC Therapeutics (Filer)
| Form ARS | |
03/13/2024
11:25 AM | ADC Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/13/2024
6:39 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
8:15 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2024
8:47 AM | ADC Therapeutics (Subject)
Prosight Management, LP (Filed by)
| Form SC 13G/A | |
02/12/2024
9:13 AM | ADC Therapeutics (Subject)
ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
| Form SC 13G/A | |
02/09/2024
8:50 PM | ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
8:45 PM | ADC Therapeutics (Issuer)
Green Jeremy (Reporting)
RedCo II Master Fund, L.P. (Reporting)
Redmile Group, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/24/2024
7:00 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
3:30 PM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
6:15 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2024
6:00 AM | ADC Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
7:00 PM | ADC Therapeutics (Issuer)
Pfisterer Thomas (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:01 PM | ADC Therapeutics (Issuer)
Sandor Victor (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:02 PM | ADC Therapeutics (Issuer)
Squarer Ron (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:04 PM | ADC Therapeutics (Issuer)
Hug Peter (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:05 PM | ADC Therapeutics (Issuer)
Zaki Mohamed (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:06 PM | ADC Therapeutics (Issuer)
Azelby Robert (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:07 PM | ADC Therapeutics (Issuer)
BIZZARI JEAN-PIERRE (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:08 PM | ADC Therapeutics (Issuer)
GRAHAM PETER J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:09 PM | ADC Therapeutics (Issuer)
Carmona Jose (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
7:10 PM | ADC Therapeutics (Issuer)
Monges Viviane (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
6:56 PM | ADC Therapeutics (Issuer)
Rivers Tyrell (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
6:58 PM | ADC Therapeutics (Issuer)
Kallebo Lisa Michelle (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
How to Make 100X on the AI Boom (Ad) For over four decades, Louis Navellier has found the very best tech stocks...
Before the rest of the market. Click for his six specific AI stock in the crosshairs |
01/02/2024
6:59 PM | ADC Therapeutics (Issuer)
MALLIK AMEET (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/19/2023
6:00 AM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/18/2023
3:25 PM | ADC Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/07/2023
6:13 AM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2023
6:16 AM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2023
6:01 AM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/08/2023
6:07 AM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/20/2023
3:14 PM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/11/2023
8:05 AM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/14/2023
3:16 PM | ADC Therapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
